Fluidigm Launches Assays and Primers to Reduce Cost of Multiplexed Analysis, Drive Instrument Sales
May 12, 2011
Fluidigm Launches Assays and Primers to Reduce Cost of Multiplexed Analysis, Drive Instrument Sales
"We expect these consumable products to help enable growth of instrument sales in the near term, and in the medium term allow us to participate significantly in the assays and primers revenue stream," said a company official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fluidigm Sees Triple-Digit Growth for NGS Sample Prep; Plans Protocols for Ion Torrent, MiSeq
May 17, 2011 / In Sequence - Fluidigm Public Offering Provides Cash Reserve as it Seeks Potential Acquisition in Reagent Space
August 23, 2012 / PCR Insider - Fluidigm Names Scandinavian Distributor
February 2, 2012 / PCR Insider - Fluidigm Taps Research Instruments as Distributor in Singapore, Thailand
October 20, 2011 / PCR Insider - Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays
October 19, 2010 / In Sequence